Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer | Zendy

Enqi Qiao | Zendy; Minghua Ji | Zendy; Jian Wu | Zendy; Jian Li | Zendy; Xinyu Xu | Zendy; Rong Ma | Zendy; Xiaohua Zhang | Zendy; Yuejun He | Zendy; Quanbin Zha | Zendy; Xue Song | Zendy; Liwei Zhu | Zendy; Jihai Tang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer

Author(s) -

Enqi Qiao,

Minghua Ji,

Jian Wu,

Jian Li,

Xinyu Xu,

Rong Ma,

Xiaohua Zhang,

Yuejun He,

Quanbin Zha,

Xue Song,

Liwei Zhu,

Jihai Tang

Publication year - 2013

Publication title -

molecular and clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.442

H-Index - 7

eISSN - 2049-9469

pISSN - 2049-9450

DOI - 10.3892/mco.2013.111

Subject(s) - immunohistochemistry , estrogen receptor , breast cancer , epidermal growth factor receptor , progesterone receptor , oncogene , cancer , clinical significance , molecular medicine , medicine , vascular endothelial growth factor , pathology , biology , oncology , cell cycle , vegf receptors

Breast cancer is one of the most common malignancies in women. This study was conducted to analyze the association between the expressions of eight immunohistochemical (IHC) indices and clinicopathological characteristics in breast cancers (BCs) and investigate the clinical significance. IHC Envision ldpe-g-nvp was used to detect the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), p53, type II topoisomerase (TOPO II) and Ki-67 in postoperative paraffin blocks of 286 cases of invasive BC and statistically analyzed their correlations with clinicopathological characteristics. The positive rates of ER, PR, HER2, VEGF, p53, EGFR, TOPO II and Ki-67 expression were 62.24, 41.96, 57.34, 53.85, 81.82, 46.85, 54.55 and 69.93%, respectively. ER expression was negatively correlated with age, tumor size and histological grade (P<0.05) and PR expression was negatively correlated with age and histological grade (P<0.05). Among the ER, PR and c-erbB-2 statuses, a significant correlation was observed between ER expression and PR status (P=0.0000), whereas the expression of ER and PR exhibited a negative correlation with HER2 status (P<0.05). We also demonstrated a significant correlation between EGFR expression and lymph node metastasis (P=0.0240), p53 expression and tumor size (P=0.0300), p53 and Ki-67 expression and histological grade (P<0.05) and the expressions of VEGF, EGFR, p53, TOPO II, Ki-67 and HER2 status (P<0.05). In addition, the Luminal B and HER2/neu subtypes exhibited a close correlation with age (P<0.01), while the HER2/neu and triple-negative subtypes were positively correlated with poor histological grade (P<0.05). In conclusion, there is a definite correlation between IHC indices and clinicopathological characteristics in BCs. Combined detection of these indices may be significant in the evaluation of biological behavior and prognosis of BC and thus in the diagnosis and comprehensive treatment of this disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research